These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18271706)

  • 21. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.
    Marder SR; Kramer M; Ford L; Eerdekens E; Lim P; Eerdekens M; Lowy A
    Biol Psychiatry; 2007 Dec; 62(12):1363-70. PubMed ID: 17601495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paliperidone-ER: first atypical antipsychotic with oral extended release formulation.
    Lautenschlager M; Heinz A
    Expert Rev Neurother; 2008 Feb; 8(2):193-200. PubMed ID: 18271706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Pani L; Marchese G
    Expert Opin Drug Deliv; 2009 Mar; 6(3):319-31. PubMed ID: 19317589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paliperidone extended-release for the treatment of schizophrenia.
    Marino J; Caballero J
    Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):873-88. PubMed ID: 22632481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania.
    Canuso CM; Battisti WP
    Expert Opin Pharmacother; 2010 Oct; 11(15):2557-67. PubMed ID: 20854185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paliperidone: a new extended-release oral atypical antipsychotic.
    Dlugosz H; Nasrallah HA
    Expert Opin Pharmacother; 2007 Oct; 8(14):2307-13. PubMed ID: 17927485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology and formulation of paliperidone extended release.
    Chue PS; MacKenzie EM; Chue JA; Baker GB
    Expert Rev Neurother; 2012 Dec; 12(12):1399-410. PubMed ID: 23237347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paliperidone extended release: a review of its use in the management of schizophrenia.
    Chwieduk CM; Keating GM
    Drugs; 2010 Jul; 70(10):1295-317. PubMed ID: 20568835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia.
    Spina E; Cavallaro R
    Expert Opin Drug Saf; 2007 Nov; 6(6):651-62. PubMed ID: 17967154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paliperidone: quo vadis?
    Citrome L
    Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paliperidone extended-release: safety and tolerability from a metabolic profile perspective.
    Rodríguez-Martínez A; Quilo CG
    Clin Drug Investig; 2013 Dec; 33(12):867-76. PubMed ID: 24241935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic.
    Owen RT
    Drugs Today (Barc); 2007 Apr; 43(4):249-58. PubMed ID: 17460786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paliperidone extended release.
    Yang LP; Plosker GL
    CNS Drugs; 2007; 21(5):417-25; discussion 426-7. PubMed ID: 17447829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.
    Gopal S; Gassmann-Mayer C; Palumbo J; Samtani MN; Shiwach R; Alphs L
    Curr Med Res Opin; 2010 Feb; 26(2):377-87. PubMed ID: 20001492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.
    Citrome L
    Int J Clin Pract; 2010 Jan; 64(2):216-39. PubMed ID: 19886879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paliperidone extended release: in adolescents with schizophrenia.
    Perry CM
    Paediatr Drugs; 2012 Dec; 14(6):417-27. PubMed ID: 23050744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paliperidone for schizophrenia.
    Dolder C; Nelson M; Deyo Z
    Am J Health Syst Pharm; 2008 Mar; 65(5):403-13. PubMed ID: 18281731
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.